TMCI

Treace Medical Concepts, Inc

$4.11

0.00 (0.00%) Today

0.16 (3.75%) Pre-market

— up— down

Compare TMCI

Market Cap

$277M-25.7%

Revenue (TTM)

$208.21M-1.7%

Net Income (TTM)

$-62,125,999

EPS (TTM)

-0.96

Shares Out

64.87M

Open

$4.27

Previous Close

$4.27

Day Range

$4.25 – $4.56

52-Week Range

$1.17 – $7.78

Beta

1.28

Volume

1.06M

Avg Volume

891.11K

Analyst Rating

Sell

Exchange

NASDAQ NMS - GLOBAL MARKET

About TMCI

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.